Harmony Acquisitions, Vimy Pharma shareholders approve business combination

Bitget2026/10/22 21:13

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Vimy Pharmaceuticals shareholders approved its combination with Harmony Acquisitions on October 22, 2026; Harmony shareholders backed the deal on October 19.
Vimy completed a $2.48 million second financing tranche, issuing 827,533 subscription receipts at $3 each.
Total financing proceeds reached $14.54 million from 4,846,354 subscription receipts, supporting product development, commercialization and working capital.
Each Vimy common share will be exchanged for one common share of the combined company.
Completion is expected in the coming weeks, with the combined company becoming Vimy Pharmaceuticals Corp., trading on the TSXV under “VIMY.”

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harmony Acquisitions Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610221712NEWSFILECNPR____20261022_320371_1) on October 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Harmony Acquisitions, Vimy Pharma shareholders approve business combination

You may also like

Crypto prices